ClinicalTrials.gov URL
EA Policies for Single Patient
While Frontier’s ultimate goal is to support patients, patient families, and patient communities by providing broad access to our investigational drug products as quickly as possible, we believe that access should be limited to controlled clinical trials until their safety and tolerability have been confirmed and the dose and dosing regimen optimized.
As such, currently, Frontier does not offer an expanded access or compassionate use program as we believe that participation in our clinical trials is the safest and most appropriate way for patients to access our investigational drug products.
We will continue to evaluate the possibility of expanded access and update our policy if our position changes.